Patents by Inventor Gregory C. Fanning

Gregory C. Fanning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
    Patent number: 7776595
    Abstract: Described are compositions and methods relating to gene therapy, particularly as applied to hematopoietic progenitor (HP) cells, to transduced cells and methods of obtaining them, and to methods of using them to provide prolonged engraftment of modified hematopoietic cells in human subjects. The invention particularly relates to ex vivo gene therapy of HP cells for treatment or prevention of HIV infection.
    Type: Grant
    Filed: August 18, 2006
    Date of Patent: August 17, 2010
    Assignee: Johnson & Johnson Research Pty, Limited
    Inventors: Geoffrey P. Symonds, Rafael G. Amado, Lun-Quan Sun, Janet L. MacPherson, Gregory C. Fanning, Wayne Gerlach
  • Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
    Patent number: 7345025
    Abstract: Described are compositions and methods relating to gene therapy, particularly as applied to hematopoietic progenitor (HP) cells, to transduced cells and methods of obtaining them, and to methods of using them to provide prolonged engraftment of modified hematopoietic cells in human subjects. The invention particularly relates to ex vivo gene therapy of HP cells for treatment or prevention of HIV infection.
    Type: Grant
    Filed: July 10, 2002
    Date of Patent: March 18, 2008
    Assignee: Johnson & Johnson Research Pty. Limited
    Inventors: Geoffrey P. Symonds, Rafael G. Amado, Lun-Quan Sun, Janet L. MacPherson, Gregory C. Fanning, Wayne Gerlach
  • Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
    Publication number: 20040072771
    Abstract: Described are compositions and methods relating to gene therapy, particularly as applied to hematopoietic progenitor (HP) cells, to transduced cells and methods of obtaining them, and to methods of using them to provide prolonged engraftment of modified hematopoietic cells in human subjects. The invention particularly relates to ex vivo gene therapy of HP cells for treatment or prevention of HIV infection.
    Type: Application
    Filed: July 10, 2002
    Publication date: April 15, 2004
    Inventors: Geoffrey P. Symonds, Rafael G. Amado, Lun -Quan Sun, Janet L. MacPherson, Gregory C. Fanning, Wayne Gerlach
  • Double-stranded RNA-mediated gene suppression
    Publication number: 20020160393
    Abstract: The present invention relates to methods for modifying gene expression and in particular to methods for controlling gene expression in eukaryotic cells using double-stranded RNA (dsRNA), and to eukaryotic cell lines in which gene expression has been altered using the method. The invention also relates to compositions suitable for controlling gene expression and to methods of treatment which utilise such compositions.
    Type: Application
    Filed: December 28, 2001
    Publication date: October 31, 2002
    Inventors: Geoffrey P. Symonds, Gregory C. Fanning, Gregory M. Arndt, Mitch Raponi, Nham Trieu Tran